These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 32771348

  • 1. The value of electrocardiography and echocardiography in distinguishing Fabry disease from sarcomeric hypertrophic cardiomyopathy.
    Junqua N, Legallois D, Segard S, Lairez O, Réant P, Goizet C, Maillard H, Charron P, Milliez P, Labombarda F.
    Arch Cardiovasc Dis; 2020; 113(8-9):542-550. PubMed ID: 32771348
    [Abstract] [Full Text] [Related]

  • 2. Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy.
    Antezana-Chavez E, Cianciulli TF, Hadid CL, Toro DD, Celano L, Saccheri MC, Baez KG, Lopez CA, Labadet CD, Gagliardi JA.
    Am J Cardiol; 2022 Sep 01; 178():131-136. PubMed ID: 35810008
    [Abstract] [Full Text] [Related]

  • 3. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease.
    Namdar M, Steffel J, Jetzer S, Schmied C, Hürlimann D, Camici GG, Bayrak F, Ricciardi D, Rao JY, de Asmundis C, Chierchia GB, Sarkozy A, Lüscher TF, Jenni R, Duru F, Brugada P.
    Am J Cardiol; 2012 Feb 15; 109(4):587-93. PubMed ID: 22105784
    [Abstract] [Full Text] [Related]

  • 4. Electrocardiographic signs of hypertrophy in fabry disease-associated hypertrophic cardiomyopathy.
    Kampmann C, Wiethoff CM, Martin C, Wenzel A, Kampmann R, Whybra C, Miebach E, Beck M.
    Acta Paediatr Suppl; 2002 Feb 15; 91(439):21-7. PubMed ID: 12572838
    [Abstract] [Full Text] [Related]

  • 5. Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15-year prospective study.
    Djordjevic DB, Tasic IS, Kostic ST, Stamenkovic BN, Lovic MB, Djordjevic ND, Koracevic GP, Lovic DB.
    Clin Cardiol; 2020 Sep 15; 43(9):1017-1023. PubMed ID: 32492247
    [Abstract] [Full Text] [Related]

  • 6. Fabry disease in cardiology practice: Literature review and expert point of view.
    Hagège A, Réant P, Habib G, Damy T, Barone-Rochette G, Soulat G, Donal E, Germain DP.
    Arch Cardiovasc Dis; 2019 Apr 15; 112(4):278-287. PubMed ID: 30826269
    [Abstract] [Full Text] [Related]

  • 7. Eelectrocardiographic correlates of ultrasonically increased septal, left ventricular posterior wall and left ventricular internal dimensions.
    Browne PJ, Benchimol A, Desser KB, Sheasby C.
    Cathet Cardiovasc Diagn; 1978 Apr 15; 4(1):15-27. PubMed ID: 148325
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T, Nagata Y, Teramoto R, Fujino N, Nomura A, Tada H, Sakata K, Furusho H, Takamura M, Nakamura H, Kawashiri MA, Yamagishi M, Hayashi K.
    Am J Cardiol; 2016 Feb 01; 117(3):443-9. PubMed ID: 26705881
    [Abstract] [Full Text] [Related]

  • 9. Chronic phase improvements in electrocardiographic and echocardiographic manifestations of left ventricular hypertrophy after alcohol septal ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Matsuda J, Kitamura M, Takayama M, Imori Y, Shibuya J, Kubota Y, Sangen H, Nakamura S, Takano H, Asai K, Shimizu W.
    Heart Vessels; 2018 Mar 01; 33(3):246-254. PubMed ID: 28965135
    [Abstract] [Full Text] [Related]

  • 10. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 Mar 01; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 11. Echocardiographic features of Fabry cardiomyopathy-Comparison with hypertrophy-matched sarcomeric hypertrophic cardiomyopathy.
    Militaru S, Jurcuț R, Adam R, Roşca M, Ginghina C, Popescu BA.
    Echocardiography; 2019 Nov 01; 36(11):2041-2049. PubMed ID: 31661576
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy.
    Dollar AL, Roberts WC.
    Am J Med; 1989 Oct 01; 87(4):377-81. PubMed ID: 2529761
    [Abstract] [Full Text] [Related]

  • 13. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
    Ishikawa J, Yamanaka Y, Watanabe S, Toba A, Harada K.
    Hypertens Res; 2019 Apr 01; 42(4):541-548. PubMed ID: 30542082
    [Abstract] [Full Text] [Related]

  • 14. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May 01; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 15. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
    Sjöberg S, Sundh F, Schlegel T, Maynard C, Rück A, Wagner G, Ugander M.
    J Electrocardiol; 2015 May 01; 48(4):630-6. PubMed ID: 25865909
    [Abstract] [Full Text] [Related]

  • 16. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products.
    Okin PM, Roman MJ, Devereux RB, Kligfield P.
    J Am Coll Cardiol; 1995 Feb 01; 25(2):417-23. PubMed ID: 7829796
    [Abstract] [Full Text] [Related]

  • 17. Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study.
    Madsen CV, Bundgaard H, Rasmussen ÅK, Sørensen SS, Petersen JH, Køber L, Feldt-Rasmussen U, Petri H.
    Scand Cardiovasc J; 2017 Aug 01; 51(4):207-216. PubMed ID: 28545342
    [Abstract] [Full Text] [Related]

  • 18. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P, Attenhofer Jost CH, Duru F, Oechslin EN, Seifert B, Widmer U, Frischknecht B, Jenni R.
    Int J Cardiol; 2006 Aug 28; 111(3):413-22. PubMed ID: 16307805
    [Abstract] [Full Text] [Related]

  • 19. Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population.
    Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K, Kaneda T, Inoue M, Fujita T, Masuta E, Funada A, Mabuchi H.
    Am J Cardiol; 2005 Nov 01; 96(9):1308-12. PubMed ID: 16253604
    [Abstract] [Full Text] [Related]

  • 20. Electrocardiographic voltage criteria in patients with hypertrophic cardiomyopathy.
    Monzo L, Martino A, Lanzillo C, Bencivenga S, Acitelli A, Fedele E, Salustri E, Bona RD, Maresca L, Silvetti E, Canestrelli S, Minati M, Penco M, Calò L.
    J Cardiovasc Med (Hagerstown); 2020 Sep 01; 21(9):696-703. PubMed ID: 32639329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.